Anthony Bergmann
Director of Finance/CFO bei CAPRICOR THERAPEUTICS, INC.
Vermögen: 16 167 $ am 31.03.2024
Profil
Anthony J.
Bergmann has held the following positions in his career: Treasurer & Finance Director at Capricor, Inc. starting in 2013, and Chief Financial Officer at Capricor Therapeutics, Inc. starting in 2018.
He completed his undergraduate degree at Providence College in 2008 and obtained an MBA from USC Marshall School of Business in 2013.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.03.2024 | 2 381 ( 0,01% ) | 16 167 $ | 31.03.2024 |
Aktive Positionen von Anthony Bergmann
| Unternehmen | Position | Beginn |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Director of Finance/CFO | 01.01.2018 |
Capricor, Inc.
 Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Director of Finance/CFO | 01.01.2012 |
Ausbildung von Anthony Bergmann
| Providence College | Undergraduate Degree |
| USC Marshall School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Health Technology |
